| 000 | 01693 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515231800.0 | ||
| 264 | 0 | _c20101012 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1880-0920 | ||
| 024 | 7 |
_a10.2133/dmpk.25.298 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAriyoshi, Noritaka | |
| 245 | 0 | 0 |
_aEnhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese. _h[electronic resource] |
| 260 |
_bDrug metabolism and pharmacokinetics _c2010 |
||
| 300 |
_a298-306 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
| 650 | 0 | 4 |
_aBiotransformation _xgenetics |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xepidemiology |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2B6 |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHLA Antigens _xgenetics |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 |
_aOxidoreductases, N-Demethylating _xgenetics |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aTiclopidine _xadverse effects |
| 700 | 1 | _aIga, Yukako | |
| 700 | 1 | _aHirata, Koji | |
| 700 | 1 | _aSato, Yasunori | |
| 700 | 1 | _aMiura, Go | |
| 700 | 1 | _aIshii, Itsuko | |
| 700 | 1 | _aNagamori, Seiji | |
| 700 | 1 | _aKitada, Mitsukazu | |
| 773 | 0 |
_tDrug metabolism and pharmacokinetics _gvol. 25 _gno. 3 _gp. 298-306 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2133/dmpk.25.298 _zAvailable from publisher's website |
| 999 |
_c19957024 _d19957024 |
||